Press release
Premenstrual Syndrome Treatment Market is Expected to Reach $1,829 Million by 2031 - AG, Eli Lilly And Company, GlaxoSmithKline Plc., H. Lundbeck A/S
Premenstrual Syndrome Treatment Market || 2024-2031
Premenstrual Syndrome (PMS) is characterized by a combination of physical and emotional symptoms such as mood swings, body aches, fatigue, tender breasts, food cravings, irritability, and depression. These symptoms typically appear toward the end of the luteal phase and subside with the onset or shortly afterward. PMS is most commonly observed in women experiencing high levels of stress, depression, hormonal fluctuations during the menstrual cycle, and chemical changes in the brain.
๐๐ฒ๐ ๐ฎ ๐๐ฟ๐ฒ๐ฒ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฃ๐๐ - https://www.datamintelligence.com/download-sample/premenstrual-syndrome-treatment-market
๐๐๐ซ๐ค๐๐ญ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ:
The global premenstrual syndrome (PMS) treatment market is expanding due to several key factors, including increased awareness of the importance of PMS treatment and growing initiatives by governments and non-governmental organizations to support women's healthcare. Additionally, advancements in new therapies are contributing to market growth.
A large target population further drives the market, as PMS is a common health issue among women of reproductive age. According to a study by Petranka Chumpalova et al. (2020) published in the Annals of General Psychiatry, around 90% of women of reproductive age experience some premenstrual symptoms, with 20-40% suffering from PMS and 2-8% experiencing premenstrual dysphoric disorder (PMDD) globally.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐ ๐๐ป๐ฎ๐น๐๐๐ถ๐
By Drug Class: Analgesics, Antidepressants, Oral Contraceptives, Ovarian Suppression Agents, Gonadotropin-releasing hormone (GnRH) Analogues, Estrogen-only patches & implants, Selective serotonin reuptake inhibitors (SSRIs), Others
By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Providers, Others
๐๐ฒ๐ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ถ๐ป ๐๐ต๐ฒ ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐ ๐ฝ๐ฒ๐ฟ ๐๐ผ๐๐ฟ ๐ฟ๐ฒ๐พ๐๐ถ๐ฟ๐ฒ๐บ๐ฒ๐ป๐๐ - https://www.datamintelligence.com/customize/premenstrual-syndrome-treatment-market
๐ ๐ฎ๐ท๐ผ๐ฟ ๐๐ฒ๐ ๐ฝ๐น๐ฎ๐๐ฒ๐ฟ๐
โข Bayer AG
โข Eli Lilly And Company
โข GlaxoSmithKline Plc.
โข H. Lundbeck A/S
โข Pfizer Inc.
โข Asarina Pharma AB
โข Chattem, Inc. (Sanofi)
โข Dekk-Tec
โข Pherin Pharmaceuticals
โข Novartis International AG
* ๐ก๐ผ๐๐ฒ:
Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.
๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป๐ฎ๐น ๐๐ป๐ฎ๐น๐๐๐ถ๐
The global Premenstrual Syndrome Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
The global Premenstrual Syndrome Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Silicone Pin Mat Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Related Reports:
Chronic Disease Management Market: https://www.datamintelligence.com/research-report/chronic-disease-management-market
Pain Management Devices Market: https://www.datamintelligence.com/research-report/pain-management-devices-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Premenstrual Syndrome Treatment Market is Expected to Reach $1,829 Million by 2031 - AG, Eli Lilly And Company, GlaxoSmithKline Plc., H. Lundbeck A/S here
News-ID: 3658037 • Views: โฆ
More Releases from DataM Intelligence 4 Market Reserach LLP
Why Is the Blood Based Biomarkers Market Growing at 14.2% CAGR to Reach US$41.43 โฆ
Market Size and Growth
The global Blood Based Biomarkers Market reached US$10.78 billion in 2025 and is projected to reach US$41.43 billion by 2035, growing at a 14.2% CAGR during 2026-2035. North America currently represents the largest regional market, while Asia-Pacific is projected to be the fastest-growing region. The market is expanding as healthcare moves toward minimally invasive diagnostics, early disease detection, longitudinal monitoring and precision medicine. Blood samples can provideโฆ
Why Is the Interoperable Health IT Systems Market Growing at 22.3% CAGR to Reach โฆ
Market Size and Growth
The global Interoperable Healthcare Information Technology (Health IT) Systems Market reached US$3.08 billion in 2024 and is projected to reach US$23.18 billion by 2033, expanding at a 22.3% CAGR during 2025-2033. The market covers solutions and services that enable secure, standardized and seamless exchange of healthcare information between EHRs, laboratories, imaging systems, pharmacies, hospitals, payers and other healthcare stakeholders.
The growth of interoperability is being driven byโฆ
Why Is the Pharma Cloud Services Market Growing at 13.9% CAGR? Inside the US$80. โฆ
Market Size and Growth
The global Pharma Cloud Services Market is projected to grow from US$19.69 billion in 2025 to US$22.43 billion in 2026, and is expected to reach US$80.98 billion by 2035, expanding at a 13.9% CAGR during 2026-2035. North America accounted for 44.27% of the global market in 2025, while Asia-Pacific is projected to record the fastest regional growth at a 13.7% CAGR during the forecast period.
The market isโฆ
AI Data Center BESS Market to Reach US$31.97 Billion by 2035 at 34.5% CAGR: How โฆ
Market Size and Growth
The AI Data Center BESS Market reached US$1.65 billion in 2025 and is projected to reach US$31.97 billion by 2035, expanding at a 34.5% CAGR during 2026-2035. North America currently represents the largest regional market, while Asia-Pacific is expected to record the fastest growth.
The rapid expansion of generative AI, GPU-intensive workloads and hyperscale computing is increasing the power density and volatility of data centers. Battery Energy Storageโฆ
More Releases for Premenstrual
PMS or PMDD? Understanding Severe Premenstrual Mood Changes
Many women notice mood shifts before their period. They may feel more emotional, tired, or irritable. This is often labeled PMS. For some, symptoms are mild and manageable. For others, they are intense and disruptive.
When mood changes become severe, especially when they affect work, school, or relationships, it may be something more serious. That condition is called PMDD.
Understanding the difference between typical premenstrual symptoms and a psychiatric condition can helpโฆ
Premenstrual Syndrome Treatment Market | $1.5 Billion by 2026 | 3.7% CAGR
Premenstrual syndrome (PMS) treatment market has witnessed exceptional growth over the years. With a robust valuation of $1,129 million in 2018, this dynamic market is poised to soar even higher, reaching an estimated value of $1,516 million by 2026. This remarkable projection reflects a steady compound annual growth rate (CAGR) of 3.7% from 2019 to 2026, underlining the increasing demand for effective PMS treatments.
The growth and success of the PMSโฆ
Premenstrual Syndrome Treatment Market: Increase in Prevalence of PMS and Premen โฆ
Premenstrual Syndrome Treatment Market Outlook 2031
-The global premenstrual syndrome treatment market was valued at US$ 1.3 Bn in 2021
-The global market is projected to grow at a CAGR of 3.4% from 2022 to 2031
-The global premenstrual syndrome treatment market is anticipated to reach more than US$ 1.9 Bn by the end of 2031
Premenstrual Syndrome Treatment Market Introduction
Premenstrual syndrome, or PMS, is the term used to describe a group of physicalโฆ
Premenstrual Dysphoric Disorder Market Healthcare, Clinical Reviews, Survey Repo โฆ
Global Premenstrual Dysphoric Disorder Market Research Report 2020-2025, this title divided by product type, applications, industry verticals, and research regions build an in-depth explanation of the perspectives, and comprehensive market statistics. The report presents a thorough analysis of the Premenstrual Dysphoric Disorder Market covering key trends, deployment models, challenges, market drivers, future roadmap, ecosystem player profiles, strategies, and value chain.
(Exclusive Offer: Up to 30% discount on this report)
Get a freeโฆ
Premenstrual Dysphoric Disorder Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Premenstrual Dysphoric Disorder Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Premenstrual Dysphoric Disorder players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Premenstrual Dysphoric Disorder with respectโฆ
Premenstrual Syndrome Global Market Research Report 2025
Premenstrual Syndrome Report by Material, Application, and Geography ๏ฟฝ Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/premenstrual-syndrome-market/80984
The report firstly introduced the Premenstrual Syndrome basics: definitions, classifications, applications andโฆ
